Stanford University
Showing 14,401-14,450 of 36,173 Results
-
Jikai Jin
Ph.D. Student in Computational and Mathematical Engineering, admitted Autumn 2023
BioI am currently a Ph.D. student of the The Institute for Computational and Mathematical Engineering (ICME) at Stanford university. Prior to joining Stanford, I obtained my bachelor degree in computational mathematics at the School of Mathematical Sciences, Peking University, fortunately having Prof. Liwei Wang as my research advisor. My research is highly interdisciplinary across machine learning, statistics, operations research. While primarily focusing on theoretical aspects, the ultimate goal of my research is to develop state-of-the-art solutions for important real-world problems.
-
Yingying Jin
Postdoctoral Scholar, Human Gene Therapy
BioYingying is a postdoctoral researcher at Kay Lab. She completed her PhD at Peking Union Medical College in China in 2024, under the supervision of Prof. De-Pei Liu. Her research focused on gene editing and ssDNA-protein interactions. During her PhD, she developed an innovative strategy to enhance HDR efficiency of ssDNA donors by incorporating HDR-boosting modules. In 2025, she joined Kay Lab, where her current work involves improving exogenous gene expression delivered by AAV through engineering the AAV genome.
-
Booil Jo
Professor of Psychiatry and Behavioral Sciences (Interdisciplinary Brain Science Research)
Current Research and Scholarly InterestsLatent Variable Modeling, Causal Inference, Longitudinal Data Analysis, Missing Data Analysis, Mixture and Growth Mixture Modeling, Prevention Science Methodology.
-
Jeyun Jo
Postdoctoral Scholar, Pathology
BioDr. Jeyun Jo received his Pharm.D. from Pusan National University in 2016 and his Ph.D. in pharmacy at the same institution in 2021. His thesis studies focused on the first total synthesis of anmindenol A and optimization of 2-anilinopyrimidine-based selective inhibitors against triple-negative breast cancer cells. He then worked for one year as a senior research scientist at Chong Kun Dang, a leading pharmaceutical company in Korea, where he developed large-sacale synthetic processes for engineered peptides. In May 2022, he joined the Bogyo lab at Stanford University as a postdoctoral fellow. His current research focuses on developing highly selective inhibitors and activity-based probes targeting specific serine hydrolases in pathogenic bacteria and cancer.
